Temozolomide - NDC Database (Page 5)
163 records found
Start a Discussion
50268-763 Mar 23, 2017
Temozolomide 140 mg Oral Capsule by Avpak
51862-083 Oct 10, 2016
Temozolomide 5 mg Oral Capsule by Mayne Pharma Inc.
51862-084 Oct 10, 2016
Temozolomide 20 mg Oral Capsule by Mayne Pharma Inc.
51862-085 Oct 10, 2016
Temozolomide 100 mg Oral Capsule by Mayne Pharma Inc.
51862-086 Oct 10, 2016
Temozolomide 140 mg Oral Capsule by Mayne Pharma Inc.
51862-087 Oct 10, 2016
Temozolomide 180 mg Oral Capsule by Mayne Pharma Inc.
51862-088 Oct 10, 2016
Temozolomide 250 mg Oral Capsule by Mayne Pharma Inc.
58181-4321 Apr 01, 2025
Temozolomide 100 mg Oral Capsule by Nextsource Biotechnology LLC
58181-4331 Apr 01, 2025
Temozolomide 140 mg Oral Capsule by Nextsource Biotechnology LLC
58181-4341 Apr 01, 2025
Temozolomide 180 mg Oral Capsule by Nextsource Biotechnology LLC
58181-4351 Apr 01, 2025
Temozolomide 250 mg Oral Capsule by Nextsource Biotechnology LLC
59923-703 Jan 25, 2019
Temozolomide 5 mg Oral Capsule by Areva Pharmaceuticals
59923-704 Jan 25, 2019
Temozolomide 5 mg Oral Capsule by Areva Pharmaceuticals
59923-705 Jan 25, 2019
Temozolomide 20 mg Oral Capsule by Areva Pharmaceuticals
59923-706 Jan 25, 2019
Temozolomide 20 mg Oral Capsule by Areva Pharmaceuticals
59923-707 Jan 25, 2019
Temozolomide 100 mg Oral Capsule by Areva Pharmaceuticals
59923-708 Jan 25, 2019
Temozolomide 100 mg Oral Capsule by Areva Pharmaceuticals
59923-709 Jan 25, 2019
Temozolomide 140 mg Oral Capsule by Areva Pharmaceuticals
59923-710 Jan 25, 2019
Temozolomide 140 mg Oral Capsule by Areva Pharmaceuticals
59923-711 Jan 25, 2019
Temozolomide 180 mg Oral Capsule by Areva Pharmaceuticals
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us .
